Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study

被引：0
作者：
Toshifumi Tada
Takashi Kumada
Hiroaki Okushin
Joji Tani
Koichi Takaguchi
Akemi Tsutsui
Hidenori Toyoda
Satoshi Yasuda
Kazufumi Dohmen
Atsushi Hiraoka
Kojiro Michitaka
Kazuhiro Nouso
Kazuya Kariyama
Soo Ryang Kim
Soo Ki Kim
Shinichi Fujioka
Shigeru Mikami
Yuto Watanabe
Tsutomu Tamai
Masanori Atsukawa
Norio Itokawa
Hironori Tanaka
Kunihiko Tsuji
Toru Ishikawa
Michitaka Imai
Ei Itobayashi
Hiroshi Shibata
Noritomo Shimada
机构：
[1] Japanese Red Cross Society Himeji Hospital,Department of Internal Medicine
[2] Gifu Kyoritsu University,Faculty of Nursing
[3] Yashima General Hospital,Department of Internal Medicine
[4] Kagawa Prefectural Central Hospital,Department of Hepatology
[5] Ogaki Municipal Hospital,Department of Gastroenterology and Hepatology
[6] Chihaya Hospital,Department of Internal Medicine
[7] Ehime Prefectural Central Hospital,Gastroenterology Center
[8] Okayama City Hospital,Department of Gastroenterology
[9] Kobe Asahi Hospital,Department of Gastroenterology
[10] Okayama Saiseikai General Hospital,Department of Gastroenterology
[11] Kikkoman General Hospital,Division of Gastroenterology, Department of Internal Medicine
[12] Kagoshima City Hospital,Department of Gastroenterology
[13] Nippon Medical School,Division of Gastroenterology and Hepatology, Department of Internal Medicine
[14] Takarazuka Municipal Hospital,Department of Gastroenterology and Hepatology
[15] Teine Keijinkai Hospital,Center of Gastroenterology
[16] Saiseikai Niigata Hospital,Department of Gastroenterology
[17] Asahi General Hospital,Department of Gastroenterology
[18] Tokushima Prefectural Central Hospital,Department of Gastroenterology
[19] Otakanomori Hospital,Division of Gastroenterology and Hepatology
来源：
Infectious Diseases and Therapy | 2021年 / 10卷
关键词：
Genotype 2; Hepatitis C virus; Ledipasvir; Sofosbuvir; Sustained virological response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：269 / 280
页数：11
相关论文
共 90 条
[1]  
Tateishi R(2017)Global prevalence and genotype distribution of hepatitis c virus infection in 2015: a modelling study Lancet GastroenterolHepatol 2 161-176
[2]  
Uchino K(2019)A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update J Gastroenterol 54 367-376
[3]  
Fujiwara N(1997)Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy Ann Intern Med 127 875-881
[4]  
Marcellin P(1997)Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C Hepatology 26 780-785
[5]  
Boyer N(2000)Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy Ann Intern Med 132 517-524
[6]  
Gervais A(1999)Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis Hepatology 29 1124-1130
[7]  
Shiffman ML(1998)Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C Ann Intern Med 129 94-99
[8]  
Hofmann CM(1999)Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT study group. Inhibition of hepatocarcinogenesis by interferon therapy Ann Intern Med 131 174-181
[9]  
Thompson EB(1998)Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C Hepatology 27 1394-1402
[10]  
Shiratori Y(2013)Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study J Hepatol 58 495-501
123456789